濮阳东方医院治疗阳痿技术值得放心-【濮阳东方医院】,濮阳东方医院,濮阳东方医院男科咨询医生,濮阳东方医院男科治阳痿靠谱,濮阳东方医院妇科收费不贵,濮阳东方医院看妇科评价好专业,濮阳市东方医院评价比较高,濮阳东方妇科医院价格非常低

BEIJING, Jan. 24 (Xinhua) -- China has invested 115 billion yuan (17.45 billion U.S. dollars) on the South-to-North Water Diversion Project as of the end of last year, a senior official said Monday.E Jingping, director of the Office of the South-to-North Water Diversion Project Commission (SNWDPC) of the State Council, said construction on 40 projects began last year, marking a new annual record.No major accidents happened while constructing the projects last year, E said.The South-to-North Water Diversion Project is designed to divert water from the water-rich south of China, mainly the Yangtze, the country's longest river, to the country's arid northern regions. It will consist of three routes: an eastern, middle and western route. The project started with construction of the eastern route in 2002.Up until now, both of the eastern and middle routes were already under construction. The western route, meant to replenish the Yellow River with water from the upper reaches of the Yangtze through tunnels in the high mountains of western China, is still in the planning stage.About 330,000 people in Hubei and Henan Provinces will be relocated before the middle route is completed in 2014.
SAN FRANCISCO, March 23 (Xinhua) -- Yahoo Inc. on Wednesday introduced a new feature to its search engine, which the company said can deliver answers and direct access to websites before users complete their query or hit the search button.The new feature, called Search Direct, predicts search results as fast as a person types and presents those results dynamically, Yahoo said."With today's launch, direct answers -- not the search results page -- is the primary focus. We are redefining the search process and prominently displaying direct answers where search decisions are being made," Shashi Seth, Yahoo's senior vice president of search and marketplaces, said in a statement."Search Direct is evidence of Yahoo continuing to lead innovation in search, enabling people to take action faster, find what is most important, and sample what is possible with the next stage of search technology," he added.Yahoo announced that Search Direct is rolling out in a public test version to its users across the United States Wednesday, and will be available in other Yahoo products and markets later this year.

BEIJING, Feb. 27 (Xinhua) -- Chinese Premier Wen Jiabao said during an online chat with netizens here Sunday that the government is striving to ensure that the people live a comfortable life with security and confidence in the period of 2011-2015.China's development blueprint for the coming five years will place high emphasis on the efforts to improve the people's livelihood, Wen said.To enhance the people's living standards is "our work's starting point as well as the final aim," he said.Greater efforts will be made to boost social development and progress, especially in those key sectors and aspects concerning national development and mass interests, the premier said.Wen began his online chat with netizens at 9 a.m. Sunday jointly hosted by the central government website (www.gov.cn) and Xinhua News Agency website (www.news.cn).
WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.
WASHINGTON, May 3 (Xinhua) -- People diagnosed with asthma in the United States grew by 4.3 million between 2001 and 2009, according to a new report released Tuesday by the Centers for Disease Control and Prevention (CDC).In 2009, nearly one in 12 Americans were diagnosed with asthma. In addition to increased diagnoses, asthma costs grew from about 53 billion U.S. dollars in 2002 to about 56 billion dollars in 2007, about a six percent increase. The explanation for the growth in asthma rates is unknown, according to the CDC.Asthma is a lifelong disease that causes wheezing, breathlessness, chest tightness, and coughing, though people with asthma can control symptoms and prevent asthma attacks by avoiding things that can set off an asthma attacks, and correctly using prescribed medicine, like inhaled corticosteroids. The report highlights the benefits of essential asthma education and services that reduce the impact of these triggers, but most often these benefits are not covered by health insurers."Despite the fact that outdoor air quality has improved, we've reduced two common asthma triggers -- secondhand smoke and smoking in general -- asthma is increasing," said Paul Garbe, chief of CDC 's Air Pollution and Respiratory Health Branch. "While we don't know the cause of the increase, our top priority is getting people to manage their symptoms better."Asthma triggers are usually environmental and can be found at school, work, home, outdoors, and elsewhere and can include tobacco smoke, mold, outdoor air pollution, and infections linked to influenza, cold-like symptoms, and other viruses.According to the report, asthma diagnoses increased among all demographic groups between 2001 and 2009, though a higher percentage of children reported having asthma than adults (9.6 percent compared to 7.7 percent in 2009). Annual asthma costs in the United States were 3,300 dollars per person with asthma from 2002 to 2007 in medical expenses. About two in five uninsured and one in nine insured people with asthma could not afford their prescription medication."Asthma is a serious, lifelong disease that unfortunately kills thousands of people each year and adds billions to our nation's health care costs," said CDC Director Thomas Frieden. "We have to do a better job educating people about managing their symptoms and how to correctly use medicines to control asthma so they can live longer more productive lives while saving health care costs."
来源:资阳报